• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术后立体定向放射治疗切除的脑转移瘤的辅助治疗。

Radiosurgery to the surgical cavity as adjuvant therapy for resected brain metastasis.

机构信息

Department of Radiation Oncology, Henry Ford Hospital, Detroit, Michigan 48202, USA.

出版信息

Neurosurgery. 2012 Nov;71(5):937-43. doi: 10.1227/NEU.0b013e31826909f2.

DOI:10.1227/NEU.0b013e31826909f2
PMID:22806080
Abstract

BACKGROUND

The standard treatment of resected brain metastasis is whole-brain radiotherapy (WBRT). To avoid the potential toxicity of WBRT and to improve local control, we have used radiosurgery alone to the surgical cavity.

OBJECTIVE

To demonstrate the rates of local control, new intracranial metastasis, and overall survival using this treatment scheme without WBRT.

METHODS

Eighty-five consecutive patients with brain metastasis were treated with surgical resection of at least 1 lesion followed by radiosurgery alone to the surgical cavity and any unresected lesions from August 2000 to March 2011. Sixty-eight percent had gross total resections. After surgery, radiosurgery was delivered to the surgical cavity with a 2- to 3-mm margin. The median marginal radiosurgery dose was 16 Gy, and median target volume was 13.96 cm. Follow-up imaging and clinical examination were obtained every 2 to 3 months.

RESULTS

Median follow-up time was 11.2 months. Overall local control was 81.2%. The 6-month, 1-year, and 2-year rates of local control were 88.7%, 81.4%, and 75.7%, respectively. Forty-seven patients (55%) developed new intracranial metastases at a median time of 5.6 months. For the entire population, the rate of new metastases was 32.1%, 58.1%, and 62.9% at 6 months, 1 year, and 2 years, respectively. Median overall survival time was 12.1 months. From initial treatment until death or last follow-up, only 30 patients (35%) received WBRT as salvage treatment.

CONCLUSION

Radiosurgery to the surgical cavity without WBRT achieved excellent local control of resected brain metastasis. Close imaging follow-up allows early intervention for any new metastasis.

摘要

背景

切除脑转移瘤的标准治疗方法是全脑放疗(WBRT)。为了避免 WBRT 的潜在毒性,并提高局部控制率,我们单独使用放射外科手术治疗手术腔。

目的

展示不使用 WBRT 仅用放射外科手术治疗手术腔和任何未切除病变的局部控制率、新颅内转移率和总生存率。

方法

2000 年 8 月至 2011 年 3 月,85 例脑转移瘤患者至少切除 1 个病灶,然后单独进行放射外科手术治疗手术腔和任何未切除的病灶。68%的患者行大体全切除。手术后,在 2 至 3mm 边缘处对手术腔进行放射外科手术治疗。边缘放射外科手术治疗的中位剂量为 16Gy,中位靶体积为 13.96cm。每 2 至 3 个月进行一次随访影像学和临床检查。

结果

中位随访时间为 11.2 个月。总体局部控制率为 81.2%。6 个月、1 年和 2 年的局部控制率分别为 88.7%、81.4%和 75.7%。47 例(55%)患者在中位时间 5.6 个月时出现新的颅内转移。对于整个患者群体,6 个月、1 年和 2 年时的新转移率分别为 32.1%、58.1%和 62.9%。中位总生存时间为 12.1 个月。从初始治疗到死亡或最后一次随访,只有 30 例(35%)患者接受了 WBRT 作为挽救治疗。

结论

不进行 WBRT 而单独对手术腔进行放射外科手术治疗可实现切除脑转移瘤的良好局部控制。密切的影像学随访可早期干预任何新的转移灶。

相似文献

1
Radiosurgery to the surgical cavity as adjuvant therapy for resected brain metastasis.术后立体定向放射治疗切除的脑转移瘤的辅助治疗。
Neurosurgery. 2012 Nov;71(5):937-43. doi: 10.1227/NEU.0b013e31826909f2.
2
Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: prospective evaluation of target margin on tumor control.脑转移瘤术后切除腔的立体定向放射外科治疗:肿瘤控制的靶区边缘的前瞻性评估。
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):336-42. doi: 10.1016/j.ijrobp.2011.12.009. Epub 2012 May 30.
3
Current dosing paradigm for stereotactic radiosurgery alone after surgical resection of brain metastases needs to be optimized for improved local control.对于手术切除脑转移瘤后单独接受立体定向放射外科治疗的患者,目前的剂量方案需要进行优化,以提高局部控制率。
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):e61-6. doi: 10.1016/j.ijrobp.2011.12.017.
4
Stereotactic irradiation of the postoperative resection cavity for brain metastasis: a frameless linear accelerator-based case series and review of the technique.基于无框架直线加速器的脑转移术后切除腔立体定向放疗:病例系列研究及技术回顾。
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):95-101. doi: 10.1016/j.ijrobp.2010.10.043. Epub 2010 Dec 17.
5
Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases.颅内转移瘤切除术后对切除腔进行立体定向放射外科治疗。
Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):486-91. doi: 10.1016/j.ijrobp.2008.04.070. Epub 2008 Oct 14.
6
Initial clinical experience with frameless radiosurgery for patients with intracranial metastases.颅内转移瘤患者的无框架放射外科手术的初步临床经验。
Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1467-72. doi: 10.1016/j.ijrobp.2004.08.021.
7
Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.早期对切除的脑转移瘤瘤床进行伽玛刀立体定向放射外科治疗以改善局部控制。
J Neurosurg. 2014 Dec;121 Suppl:69-74. doi: 10.3171/2014.7.GKS141488.
8
Gamma Knife surgery targeting the resection cavity of brain metastasis that has progressed after whole-brain radiotherapy.伽玛刀手术针对全脑放疗后进展的脑转移瘤切除腔。
J Neurosurg. 2006 Dec;105 Suppl:75-8. doi: 10.3171/sup.2006.105.7.75.
9
Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.立体定向放射外科加强治疗寡转移脑疾病的切除床:挑战辅助全脑放疗的传统
Neurosurg Focus. 2009 Dec;27(6):E7. doi: 10.3171/2009.9.FOCUS09191.
10
Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size.术后立体定向放射外科治疗脑转移瘤而不进行全脑放疗:术前肿瘤大小的潜在作用。
Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):650-5. doi: 10.1016/j.ijrobp.2012.05.027. Epub 2012 Jul 12.

引用本文的文献

1
A prospective study of minimally invasive keyhole craniotomy and stereotactic brachytherapy for new brain oligometastases.一项关于微创锁孔开颅术和立体定向近距离放射治疗新发脑寡转移瘤的前瞻性研究。
J Neurooncol. 2025 Jun 7. doi: 10.1007/s11060-025-05077-y.
2
Adjuvant radiotherapy after brain metastasectomy: analysis of consecutive cohort of 118 patients from real world practice.脑转移瘤切除术后辅助放疗:来自真实临床实践的118例连续队列分析。
Rep Pract Oncol Radiother. 2024 Mar 18;29(1):30-41. doi: 10.5603/rpor.99362. eCollection 2024.
3
Intraoperative radiotherapy after neurosurgical resection of brain metastases as institutional standard treatment- update of the oncological outcome form a single center cohort after 117 procedures.
神经外科切除脑转移瘤术后术中放疗作为机构标准治疗-单中心队列 117 例后肿瘤学结果的更新。
J Neurooncol. 2024 Aug;169(1):187-193. doi: 10.1007/s11060-024-04691-6. Epub 2024 Jul 4.
4
Intraoperative radiotherapy for brain metastases: first-stage results of a single-arm, open-label, phase 2 trial.脑转移瘤的术中放疗:一项单臂、开放标签的2期试验的第一阶段结果。
J Neurooncol. 2023 Mar;162(1):211-215. doi: 10.1007/s11060-023-04266-x. Epub 2023 Feb 24.
5
Gamma Knife Radiosurgery Irradiation of Surgical Cavity of Brain Metastases: Factor Analysis and Gene Mutations.伽玛刀放射外科治疗脑转移瘤手术腔:因素分析与基因突变
Life (Basel). 2023 Jan 14;13(1):236. doi: 10.3390/life13010236.
6
Neoadjuvant stereotactic radiosurgery for brain metastases: a new paradigm.立体定向放射外科治疗脑转移瘤的新范例
Neurosurg Focus. 2022 Nov;53(5):E8. doi: 10.3171/2022.8.FOCUS22367.
7
Intraoperative radiotherapy with low-energy x-rays after neurosurgical resection of brain metastases-an Augsburg University Medical Center experience.脑转移瘤神经外科切除术后低能 X 射线术中放疗:奥格斯堡大学医学中心的经验。
Strahlenther Onkol. 2021 Dec;197(12):1124-1130. doi: 10.1007/s00066-021-01831-z. Epub 2021 Aug 20.
8
Stereotactic Radiosurgery to Prevent Local Recurrence of Brain Metastasis After Surgery: Neoadjuvant Versus Adjuvant.立体定向放射外科手术预防脑转移瘤术后局部复发:新辅助治疗与辅助治疗对比
Acta Neurochir Suppl. 2021;128:85-100. doi: 10.1007/978-3-030-69217-9_9.
9
Current status and recent advances in resection cavity irradiation of brain metastases.脑转移瘤切除腔照射的现状和最新进展。
Radiat Oncol. 2021 Apr 15;16(1):73. doi: 10.1186/s13014-021-01802-9.
10
A Dose-Response Model of Local Tumor Control Probability After Stereotactic Radiosurgery for Brain Metastases Resection Cavities.脑转移瘤切除腔立体定向放射外科治疗后局部肿瘤控制概率的剂量反应模型。
Adv Radiat Oncol. 2020 Jun 24;5(5):840-849. doi: 10.1016/j.adro.2020.06.007. eCollection 2020 Sep-Oct.